Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Re...

por Leite, Caio Abner, Carvalho, Raíssa Pierri, da Costa, Felipe Marques, Medeiros, Augusto Kreling, Schutz, Fabio Augusto, William, William Nassib
Publicado 2023

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective

por Sade, Juan Pablo, Báez, Carlos Alberto Vargas, Greco, Martin, Martínez, Carlos Humberto, Avitia, Miguel Ángel Álvarez, Palazzo, Carlos, Toriz, Narciso Hernández, Trujillo, Patricia Isabel Bernal, Bastos, Diogo Assed, Schutz, Fabio Augusto, Bella, Santiago, Nogueira, Lucas, Shore, Neal D.
Publicado 2018

Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

por Schutz, Fabio Augusto Barros, Sirachainan, Ekaphop, Kuppusamy, Shanggar, Hoa, Nguyen Thi Thai, Dejthevaporn, Thitiya, Bahadzor, Badrulhisham, Toan, Vu Quang, Chansriwong, Phichai, Alip, Adlinda, Hue, Nguyen Thi Minh, Parinyanitikul, Napa, Tan, Ai Lian, Hoang, Vu Dinh Khanh, Tienchaiananda, Piyawan, Chinchapattanam, Sai Naga Deepak, Garg, Amit
Publicado 2021

Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician'...

por Maluf, Fernando, Soares, Andrey, Avanço, Guilherme, Hada, Aline Lury, Cardoso, Ana Paula Garcia, Carneiro, Arie, Herchenhorn, Daniel, Jardim, Denis Leonardo Fontes, Schutz, Fabio Augusto, Kater, Fabio Roberto, Pereira, Felipe Moraes Toledo, Monteiro, Fernando Sabino Marques, Morbeck, Igor Alexandre Protzner, Reolon, João Francisco Navarro, da Trindade, Karine Martins, Andrade, Livia Maria Querino da Silvo, Nogueira, Lucas Mendes, Furoni, Renato, Natel, Ricardo Azze, dos Reis, Rodolfo Borges, Fogace, Rodrigo Nogueira, Souza, Vinicius Carrera
Publicado 2021